University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...

Genentech, a member of Roche (RHHBY), announced that a detailed analysis of its Phase III REGENCY trial of Gazyva in people with active lupus ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...

New England Business Media ... a daily update of the area’s most important business news. Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Post-lockdown, child mortality rates in England increased, revealing significant disparities and ongoing challenges in ...

The "Augusta!" logo will not comply with upcoming new requirements under the federal Americans with Disabilities Act, city councilors were told last week. An error ...

"To promote the science and art of medicine and the betterment of public health." The A.M.A. has pursued its twin goals vigorously over these many years and has demonstrated a distinct and ...